Johnson & Johnson pauses Covid-19 vaccine trial after “unexplained illness”
Drugmaker Johnson & Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers.
“Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have prespecified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,” the company said.
You may be interested
Greek-Turkish crisis: Greek diplomatic counterattack on all frontsmakis - Oct 19, 2020
Greece is taking multifaceted diplomatic initiatives to denounce Turkish actions, given the unprecedented and escalating Turkish behavior. According to information,…
Covid-19 Greece – 508 new cases reported on Fridaymakis - Oct 16, 2020
The Hellenic National Public Health Organization (EODY) announced on Friday 508 new Covid-19 cases – a negative record, of which…
PM Mitsotakis: EU should be consistent in the face of Turkish provocationsmakis - Oct 15, 2020
Greek PM Kyriakos Mitsotakis urged the European Union to show consistency in the light of Turkey’s provocations, arriving at the…